Below are the most recent publications written about "European Union" by people in Profiles.
-
Goodall R, Alazawi A, Hughes W, Bravis V, Salciccioli JD, Marshall DC, Crowley C, Shalhoub J. Trends in type 2 diabetes mellitus disease burden in European Union countries between 1990 and 2019. Sci Rep. 2021 07 28; 11(1):15356.
-
Kay J. Overcoming barriers to biosimilars in inflammatory arthritis. Nat Rev Rheumatol. 2020 Feb; 16(2):65-66.
-
Solecki R, Kortenkamp A, Bergman ?, Chahoud I, Degen GH, Dietrich D, Greim H, H?kansson H, Hass U, Husoy T, Jacobs M, Jobling S, Mantovani A, Marx-Stoelting P, Piersma A, Ritz V, Slama R, Stahlmann R, van den Berg M, Zoeller RT, Boobis AR. Scientific principles for the identification of endocrine-disrupting chemicals: a consensus statement. Arch Toxicol. 2017 Feb; 91(2):1001-1006.
-
Kortenkamp A, Bourguignon JP, Slama R, Bergman ?, Demeneix B, Ivell R, Panzica G, Trasande L, Zoeller RT. EU regulation of endocrine disruptors: a missed opportunity. Lancet Diabetes Endocrinol. 2016 08; 4(8):649-650.
-
Bourguignon JP, Slama R, Bergman ?, Demeneix B, Ivell R, Kortenkamp A, Panzica G, Trasande L, Zoeller RT. Science-based regulation of endocrine disrupting chemicals in Europe: which approach? Lancet Diabetes Endocrinol. 2016 08; 4(8):643-646.
-
Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Hunt PM, Rudel R, Sathyanarayana S, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology. 2016 07; 4(4):565-72.
-
Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L. Response to the Letter by Middlebeek and Veuger. J Clin Endocrinol Metab. 2015 Jun; 100(6):L54-5.
-
Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab. 2015 Apr; 100(4):1245-55.
-
Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015 Apr; 100(4):1256-66.
-
Bergman ?, Andersson AM, Becher G, van den Berg M, Blumberg B, Bjerregaard P, Bornehag CG, Bornman R, Brandt I, Brian JV, Casey SC, Fowler PA, Frouin H, Giudice LC, Iguchi T, Hass U, Jobling S, Juul A, Kidd KA, Kortenkamp A, Lind M, Martin OV, Muir D, Ochieng R, Olea N, Norrgren L, Ropstad E, Ross PS, Rud?n C, Scheringer M, Skakkebaek NE, S?der O, Sonnenschein C, Soto A, Swan S, Toppari J, Tyler CR, Vandenberg LN, Vinggaard AM, Wiberg K, Zoeller RT. Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors. Environ Health. 2013 Aug 27; 12:69.